-
Reputation and Its Risks
Public relations Magazine ArticleIdentify, quantify, and manage the risks to your company’s reputation long before a problem or crisis strikes. -
Ending the War Between Sales and Marketing
Business communication Magazine ArticleIn many companies, sales forces and marketers feud like Capulets and Montagues—with disastrous results. Here’s how to get them to lay down their swords. -
Who Has the D?: How Clear Decision Roles Enhance Organizational Performance
Decision making and problem solving Magazine ArticleYour organization can become more decisive—and can implement strategy more quickly—if you know where the bottlenecks are and who’s empowered to break through them. -
All the Wrong Moves
Decision making and problem solving Magazine ArticleNutrorim’s best-selling sports supplement has been recalled because of a “new and improved” ingredient. The company’s CEO wonders: Why do the decisions we make keep coming back to haunt us? -
How Much Cash Does Your Company Need?
Finance & Accounting Magazine ArticleIn late 2001, the directors of Pfizer asked that very question. And with good reason. After its 2000 merger with rival Warner-Lambert, the New York-based... -
3 Business Models That Could Bring Million-Dollar Cures to Everyone
Innovation Digital ArticleGene therapy is a medical breakthrough, but today it’s prohibitively expensive. -
Decisions Without Blinders
Organizational Development Magazine ArticleBy the time Merck withdrew its pain relief drug Vioxx from the market in 2004, more than 100 million prescriptions had been filled in the United States... -
"A Players" or "A Positions"? The Strategic Logic of Workforce Management
Organizational Development Magazine ArticleCompanies simply can't afford to have "A players" in all positions. Rather, businesses need to adopt a portfolio approach to workforce management, systematically... -
Leadership Run Amok: The Destructive Potential of Overachievers
Organizational Development Magazine ArticleThe desire to achieve is a major source of strength in business, and it is on the rise. The authors' consulting firm has seen a steady increase in the... -
Who Goes, Who Stays? (Commentary for HBR Case Study)
Leadership & Managing People Magazine ArticleThe merger announcement between DeWaal Pharmaceuticals and BioHealth Labs was front-page news. Two months later, the press had moved on to a new story,... -
What Executives Should Remember
Leadership & Managing People Magazine ArticleIn more than 30 essays for Harvard Business Review, Peter Drucker (1909-2005) urged readers to take on the hard work of thinking--always combined, he... -
Can One Business Unit Have 2 Revenue Models? (HBR Case Study and Commentary)
Strategy & Execution Magazine ArticlePeter Noll, a pharmaceutical company division chief, ponders the varying business models of two units that have just merged. Both have for years employed... -
A More Rational Approach to New-Product Development
Innovation & Entrepreneurship Magazine ArticleCompanies often treat new-product development as a monolithic process, but it can be more rationally divided into two parts: an early stage that focuses... -
3 Actions Congress Can Take to Reduce Drug Prices
Global Business Digital ArticleSaving patients money doesn't have to hurt business. -
Managing Authenticity: The Paradox of Great Leadership
Leadership & Managing People Magazine ArticleLeaders and followers both associate authenticity with sincerity, honesty, and integrity. It's the real thing--the attribute that uniquely defines great... -
Putting Customers in the “Wish Mode”
Customer experience Magazine ArticleDon’t settle for just making your product better. Let your customers make it great. -
The CEO of Pfizer on Developing a Vaccine in Record Time
Leadership & Managing People Magazine ArticleOn March 19, 2020, as Covid-19 swept across the world, Bourla challenged everyone at Pfizer and its partner BioNTech--a German company focused on cancer... -
Conquering a Culture of Indecision (HBR Classic)
Organizational Development Magazine ArticleThe single greatest cause of corporate underperformance is the failure to execute. According to author Ram Charan, such failures usually result from misfires... -
From Managing Pills to Managing Brands
Sales & Marketing Magazine ArticleData show that the top-selling drugs today are not the products of breakthrough science. That's why drug companies need to learn the lessons of marketing... -
3-D Negotiation: Playing the Whole Game
Strategy & Execution Magazine ArticleWhat stands between you and the yes you want? According to negotiation experts David Lax and James Sebenius, executives face obstacles in three common...
-
Alvogen
Innovation & Entrepreneurship Case Study8.95View Details Alvogen is a young Icelandic generic pharmaceutical company, whose CEO believes that his global strategy will give them an edge in this competitive industry.... -
Merck, Darmstadt: Sustaining Legacy Beyond 350 Years
Leadership & Managing People Case Study8.95View Details This case is about the business, governance and leadership transformation of Merck - a 13th generation, family-owned, German multinational group operating... -
Taurion Inc.: Built to Cure an Incurable Disease (VCs)
Finance & Accounting Case Study5.00View Details Supplement to case IES519. Taurion Inc. is a start-up company established in 2006 and based in Vienna. It specializes in researching the causes of Alzheimer's... -
Reintroduce Thalidomide? (A)
Strategy & Execution Case Study8.95View Details In the 1960s thalidomide, a popular new drug considered to be safe and effective, was revealed to cause severe nerve damage and birth defects in newborn... -
Labour Dispute at Dr. Reddy's: Tip of the Iceberg in a Globalization Effort
Leadership & Managing People Case Study8.95View Details The case describes a dispute between the management of Dr. Reddy's and a trade union over the employment terms of contract workers. However, as events... -
Genzyme Corp.: Strategic Challenges with Ceredase
Strategy & Execution Case Study8.95View Details Genzyme Corp., one of the largest biotechnology companies, has succeeded in developing, manufacturing, and commercializing its first therapeutic, a treatment... -
Puritan Drug Co.
Sales & Marketing Case Study8.95View Details David Thomas takes his first sales management assignment and is faced with a sales rep revolt because of a possible territory reorganization. In addition,... -
Reintroduce Thalidomide? (B)
Strategy & Execution Case Study5.00View Details An abstract is not available for this product. -
Genetic Testing and the Puzzles We Are Left To Solve (A): Consideration for Family Members
Technology & Operations Case Study8.95View Details This set of cases (labeled A through M [UV1898 through UV1911]) presents various vignettes, each with a specific dilemma about genetic testing and the... -
Merck: Managing Vioxx (F)
Finance & Accounting Case Study5.00View Details -
Kendle International, Inc.
Finance & Accounting Case Study8.95View Details Candace Kendle and Christopher Bergen, the CEO and COO of Kendle International, Inc., are reviewing ways to finance the growth of their privately-owned... -
Building an Integrated Biopharma Company: Crucell (B)
Innovation & Entrepreneurship Case Study5.00View Details The Crucell (B) case updates events at Crucell since 2009. In September, 2009, Johnson & Johnson acquired 18% of Crucell for $400 million. This investment... -
Zantac (B)
Sales & Marketing Case Study5.00View Details Supplement to case IN1271. The cases describe the development, worldwide launch, and subsequent marketing of a new pharmaceutical product which, although... -
Treu Pharma: Role for Alex Hoffman
Leadership & Managing People Case Study8.95View Details No Abstract -
Price-Fixing Vignettes
Strategy & Execution Case Study8.95View Details This case escribes the antitrust prosecutions in the United States and abroad of the international bulk vitamins cartel. Both the civil and criminal fines... -
Genetic Testing and the Puzzles We Are Left To Solve (B): How Test Accuracy Levels Can Alter Decisions
Technology & Operations Case Study5.00View Details This set of cases (labeled A through M [UV1898 through UV1911]) presents various vignettes, each with a specific dilemma about genetic testing and the... -
PROPECIA: Helping Make Hair Loss History
Sales & Marketing Case Study8.95View Details In late 1997, Tom Casola, brand manager for Propecia, debates the best approach to market this breakthrough one-a-day pill for hair loss. This launch... -
Novartis Pharma: The Business Unit Model
Finance & Accounting Case Study8.95View Details In June 2000, Novartis reorganized its pharmaceutical business to form global business units in oncology, transplantation, ophthalmology, and mature products.... -
Cost Plus Drugs
Strategy & Execution Case Study8.95View Details In September 2022, Mark Cuban Cost Plus Drugs Company CEO Alex Oshmyansky considered the future of the company. Cost Plus Drugs was a retailer for more... -
Merck: Managing Vioxx (G)
Finance & Accounting Case Study5.00View Details
-
Reputation and Its Risks
Public relations Magazine ArticleIdentify, quantify, and manage the risks to your company’s reputation long before a problem or crisis strikes. -
Ending the War Between Sales and Marketing
Business communication Magazine ArticleIn many companies, sales forces and marketers feud like Capulets and Montagues—with disastrous results. Here’s how to get them to lay down their swords. -
Who Has the D?: How Clear Decision Roles Enhance Organizational Performance
Decision making and problem solving Magazine ArticleYour organization can become more decisive—and can implement strategy more quickly—if you know where the bottlenecks are and who’s empowered to break through them. -
Alvogen
Innovation & Entrepreneurship Case Study8.95View Details Alvogen is a young Icelandic generic pharmaceutical company, whose CEO believes that his global strategy will give them an edge in this competitive industry.... -
Novo Nordisk Engineering: Running for Fast-Track Project Execution, Teaching Note
Organizational Development Digital ArticleTeaching Note for [IMD422]. -
McKesson, Teaching Plan
Strategy & Execution Digital ArticleTeaching Plan for 312002. -
Merck, Darmstadt: Sustaining Legacy Beyond 350 Years
Leadership & Managing People Case Study8.95View Details This case is about the business, governance and leadership transformation of Merck - a 13th generation, family-owned, German multinational group operating... -
Merck, Darmstadt: Sustaining Legacy Beyond 350 Years, Teaching Note
Leadership & Managing People Digital ArticleTeaching note for case ISB123. -
Taurion Inc.: Built to Cure an Incurable Disease (VCs)
Finance & Accounting Case Study5.00View Details Supplement to case IES519. Taurion Inc. is a start-up company established in 2006 and based in Vienna. It specializes in researching the causes of Alzheimer's... -
Bayer's Innovation Agenda: Igniting Innovation in a 100,000-Person Company, Teaching Note
Innovation & Entrepreneurship Digital ArticleTeaching note for case LBS208.